Abstract Simple, rapid and sensitive spectroscopic methods were developed and validated for the determination of antiviral agents, namely, penciclovir (PCV) and entecavir (ETV). The first method is based on measuring the native fluorescence of each of the cited drugs at its optimum excitation and emission wavelengths. The fluorescence intensity was measured for PCV & ETV at 363 nm and 370 nm upon excitation at 260 nm and 254 nm, respectively. The calibration curves were linear over the concentration range 0.1-0.8, 0.025-0.4 lg ml À1 for PCV and ETV, respectively. The second method is based on measuring the amplitude of ETV in the fourth derivative with Dk = 8 and scaling factor = 100 at 256.4 nm at which its acidic degradation showed zero reading over the concentration range 5-60 lg ml
Introduction
Penciclovir (PCV), [2-amino-9 -[4-hydroxy-3-(hydroxymethyl) butyl]-6,9-dihydro-3H-purin-6-one] and entecavir (ETV), [2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-meth ylidenecyclopentyl]-6,9-dihydro-3H-purin-6-one] are antiviral drugs, Fig. 1 . [1] [2] [3] PCV and ETV are nucleoside analogs, more specifically guanosine analogs, that inhibit reverse transcription, DNA replication and transcription in the viral replication process by inhibiting DNA polymerase. 4, 5 A detailed survey of analytical literature of PCV revealed several methods based on various techniques, HPLC using UV 6,7 fluorescence [8] [9] [10] [11] and mass spectrometry 12, 13 as detectors and capillary zone electrophoresis.
14 Besides, different analytical methods for the determination of ETV have been reported, including UV-spectrophotometry, 15, 16 HPLC using UV [17] [18] [19] and mass spectrometry [20] [21] [22] [23] [24] as detectors, and capillary zone electrophoresis. 25 Accordingly, the literature revealed that there is no reported spectrofluorimetric method for the determination of PCV or ETV although they have native fluorescence which represents a direct method for the determination of the two drugs. Moreover, no spectrophotometric method has been reported for the determination of ETV in the presence of its acidic degradation. Thus, the development of these spectroscopic methods for the determination of the cited drugs in bulk and pharmaceutical preparations were of interest. Moreover, the device used for the determination is available in each QC laboratory.
Experimental

Instrumentation
A Shimadzu RF-1501 spectrofluorimetric (Kyoto-Japan). A Crest ultrasonic processor model 575DAE (USA). Electronic balance model HR200 (USA). UV Shimadzu UV/Visible recording spectrophotometer 1601 (Japan) connected to an IBM compatible computer and supported with UV probe software version 2.2.1. Ten tablets were accurately weighed and a quantity equivalent to 2 mg ETV was transferred to a 100 ml volumetric flask. Twenty ml of 0.1 M H 2 SO 4 was added and the solution was sonicated for 15 min then completed to volume using the same solvent. The solution was filtered through filter paper to obtain a test solution of concentration 20 lg ml À1 .
Reagents and reference samples
. Further dilution was done using 0.1 M H 2 SO 4 to obtain a final concentration of 1 lg ml À1 .
For derivative method.
Ten Hepaclude tablets were accurately weighed and a quantity equivalent to 5 mg entecavir was transferred to a 25 ml volumetric flask. Ten ml distilled water was added and the solution was sonicated for 15 min then completed to volume using the same solvent and the solution was filtered to obtain a test solution of concentration 200 lg ml À1 .
Preparation of acidic ETV degradation stock solution
Entecavir (100 mg) was refluxed in 25 ml 5 N HCl for 72 h at 70°C. An aliquot (1 ml) of this solution was neutralized using 5 N NaOH then completed to 100 ml in a volumetric flask with distilled water to prepare acidic ETV degradation stock solution containing degradation equivalent to 40 lg ml À1 of ETV.
General procedures and calibrations
For spectrofluorimetric method
Accurately measured aliquots of working standard solutions equivalent to 0.1-0.8 and 0.025-0.4 lg ml À1 of PCV and ETV respectively were separately transferred into two sets of 10 ml volumetric flasks; then each flask was completed to volume with 0.1 M H 2 SO 4 . The native fluorescence intensity (F) was measured and used to plot a curve against concentration (C), and the regression parameters were computed for each drug.
For derivative method
Accurately measured aliquots of working standard solutions equivalent to 5-60 lg ml À1 ETV were separately transferred into 10 ml volumetric flasks; then each flask was completed to volume with distilled water. The amplitude after the derivatization (A) with Dk = 8 and scaling factor = 100 at 256.4 nm at which its acidic degradation showed zero reading, was measured and used to plot a curve against concentration (C), and the regression parameters were computed. Selection of excitation wavelengths of PCV and ETV was based on the maximum wavelength of absorption in UV region. Optimum excitation wavelengths found for PCV and ETV were 260 nm and 254 nm, respectively. Also, selection of suitable emission wavelength was done by scanning the emission spectra and measuring the variation in emission intensity wavelength at a fixed excitation wavelength. Optimum emission wavelengths were found to be 363 nm, 370 nm, at their selected excitation wavelengths for PCV and ETV, respectively. The fluorescence emission spectra of PCV and ETV are shown in Fig. 2 . Sulfuric acid was found to be more suitable than water as solvent with lowest background noise at the selected excitation and emission wavelengths for PCV and ETV while water shows no emission with the selected drugs. Moreover, sulfuric acid gives satisfactory results along with the experimental results.
The absorption spectrum of each solution of the calibration curve was recorded (Fig. 3) .The fourth derivative of the represented spectra of ETV standard and ETV acidic degradation products were plotted with Dk = 8 and scaling factor = 100 at 256.4 nm at which its degradation showed zero reading (Fig. 4) .
Method validation
Linearity
Linearity was studied for the two cited drugs PCV and ETV.
In this study, 6 concentrations for each drug were used. A linear relationship between the fluorescence intensity or the amplitude and the component concentration (C) was obtained.
Range of linearity and regression equation: y = bc ± a for each drug is mentioned in Table 1 . The linearity of the calibration curves was validated by the high values of correlation coefficients. The analytical data of the calibration curves including standard deviations for the slope and intercept and other characteristics are summarized in Table 1 .
Accuracy
Accuracy of the results was checked by calculating % recovery of six different concentrations of PCV and ETV and also by applying the standard addition technique to the pharmaceutical preparations, all carried out in triplicate. The results Tables 1 and 2 .
Precision
Precision was estimated by repeatability which was assessed by analyzing a solution of 30 lg ml À1 and 0.1 lg ml À1 of ETV (n = 6) for derivative spectrophotometric method & spectrofluorimetric method, respectively, and a solution of 0.5 lg ml À1 of PCV for the spectrofluorimetric method. The values of the precision (% R.S.D) of repeatability along with intraday and inter-day precision (using 3 different concentrations in triplicate for three consecutive days) for the two drugs are displayed in Tables 1 and 2 .
Specificity
Specificity is the ability of the analytical method to identify the analyte response in the presence of any interference. In the present work, the spectra of the samples of the dosage form were checked for the appearance of any new spectra of the excipients. No interference from any of the excipients was found at the excitation/emission wavelengths of the examined drugs and in the fourth derivative spectroscopic method. In addition, Table 1 Validation data of the analysis of PCV and ETV using the proposed spectrofluorimetric method. the spectrum of each drug in the sample solution is identical to that received by the standard solution at the wavelengths applied. Besides, good recoveries were obtained for the samples. Moreover, the derivative spectrophotometric method was able to determine ETV without any interference from its acidic degradation product.
Limit of detection and limit of quantification
Limit of detection (LOD) which represents the concentration of analyte at SD/S ratio of 3.3 and limit of quantification (LOQ) at which SD/S is 10, were determined for the proposed method, and results are given in Table 1 .
Statistical analysis
A statistical analysis of the results obtained by the proposed spectroscopic methods for the determination of PCV and ETV and those obtained by the manufacturer reported methods was carried out by ''SPSS statistical package version 11", as shown in Table 3 . The test ascertained that there was no significant difference between the proposed method and the reference methods reported by the manufacturer by using the independent t-value (2.23) at P < 0.05 (Table 3 ).
Conclusion
The proposed spectroscopic methods have the advantage of simplicity, precision, accuracy, and convenience for the determination of the cited antiviral drugs: penciclovir and entecavir. Hence, the proposed methods can be used for the routine quality control of the cited drugs in bulk and in pharmaceutical preparations in laboratories.
